photo of Dr Ryan Toh

Dr Ryan Toh

Dr Ryan Toh

Details

Role Senior Research Officer
Dr Ryan Toh completed his PhD in the Department of Paediatrics at the University of Melbourne in 2017. He started his role as a Research Officer in the New Vaccines Research Group in 2018 under the supervision of Professor Kim Mulholland and Associate Professor Paul Licciardi.

Ryan's research interests include exploring alternative human papillomavirus (HPV) vaccination strategies such as reduced-dose schedule and targeted vaccination of high-risk groups, to improve vaccine uptake in resource-limited settings. He has been involved in several vaccine clinical trials and has acquired considerable experience in several microbiological and immunological techniques. He has presented at numerous scientific meetings and published more than 40 manuscripts and book chapters.
Dr Ryan Toh completed his PhD in the Department of Paediatrics at the University of Melbourne in 2017. He started his role as a Research Officer in the New Vaccines Research Group in 2018 under the supervision of Professor Kim Mulholland and Associate...
Dr Ryan Toh completed his PhD in the Department of Paediatrics at the University of Melbourne in 2017. He started his role as a Research Officer in the New Vaccines Research Group in 2018 under the supervision of Professor Kim Mulholland and Associate Professor Paul Licciardi.

Ryan's research interests include exploring alternative human papillomavirus (HPV) vaccination strategies such as reduced-dose schedule and targeted vaccination of high-risk groups, to improve vaccine uptake in resource-limited settings. He has been involved in several vaccine clinical trials and has acquired considerable experience in several microbiological and immunological techniques. He has presented at numerous scientific meetings and published more than 40 manuscripts and book chapters.

Top Publications

  • Ong, DS, Phan, TV, Temple, B, Toh, ZQ, Nguyen, CD, Vientrung, K, Nguyen, HVA, Thi Trang Dai, V, Bright, K, Tran, HP, et al. Memory B cell responses induced by pneumococcal conjugate vaccine schedules with fewer doses: analysis of a randomised-controlled trial in Viet Nam.. Nat Commun 15(1) : 6968 2024
    view publication
  • Niyomnaitham, S, Chokephaibulkit, K, Pheerapanyawaranun, C, Toh, ZQ, Licciardi, PV, Satayasanskul, A, Jansarikit, L, Assantachai, P. Immunogenicity of BNT162b2 as a first booster after a ChAdOx1 primary series in a Thai geriatric population living with frailty.. J Nutr Health Aging 28(8) : 100315 2024
    view publication
  • Quang, C, Chung, AW, Kemp, TJ, Ratu, T, Tuivaga, E, Russell, FM, Licciardi, PV, Toh, ZQ. Development of a human papillomavirus (HPV) multiplex immunoassay to profile HPV antibodies.. J Med Virol 96(6) : e29732 2024
    view publication
  • Piyaphanee, N, Charuvanij, S, Thepveera, S, Toh, ZQ, Licciardi, PV, Pattaragarn, A, Wongprompitak, P, Boonnak, K, Pheerapanyawaranun, C, Chokephaibulkit, K. Immunogenicity and safety of BNT162b2 vaccination in adolescents with systemic lupus erythematosus.. Lupus 33(5) : 450 -461 2024
    view publication
  • Tosif, S, Neeland, M, Sutton, P, Licciardi, P, Sarkar, S, Selva, K, Do, LAH, Donato, C, Toh, ZQ, Higgins, R, et al. Immune responses to SARS-CoV-2 in children of parents with symptomatic COVID-19. 2024
    view publication

Page 1 of 16

Career information